Severe Ketoacidosis as the First Clinical Manifestation of Type 1 Diabetes Mellitus Secondary to Immune Checkpoint Inhibitors

by Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Araceli R. García-Domínguez, Juan J. Cruz-Hernández
Published 2020-04-01

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

by Alejandro Olivares-Hernández, Luis Figuero-Pérez, María A. Amores Martín, Lorena Bellido Hernández, Laura Mezquita, María del Rosario Vidal Tocino, Félix López Cadenas, Felipe Gómez-Caminero López, Roberto A. Escala-Cornejo, Juan Jesús Cruz Hernández
Published 2021-01-01